Other
Metformin
0
Pipeline Programs↗
36
Active Trials↗
45
Companies Involved↗
Metformin is an early-stage landscape with 0 programs across 45 companies. The most active players are Boehringer Ingelheim, Johnson & Johnson, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
383
clinical trials
Completed274 · 72%
Unknown status41 · 11%
Terminated19 · 5%
Recruiting16 · 4%
Not yet recruiting13 · 3%
Withdrawn12 · 3%
Other8 · 2%
Clinical Trials
Trial Activity
383 trials
Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy
Recruiting·KKaohsiung Medical University Chung-Ho Memorial Hospital·Phase 2·NCT06826092·110 enrolled
Managing Chronic Tendon Pain by Metformin
Recruiting·—·Phase 1·NCT06100822·40 enrolled
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
Recruiting·—·Phase 3·NCT05230758·140 enrolled
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Recruiting·—·Phase 3·NCT03925701·120 enrolled
Page 1 of 26
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)